CRISPR patent splits former colleagues

Emmanuelle Charpentier of the Helmholtz Centre for Infection Research and Jennifer Doudna of the University of California, Berkeley, are pioneers in the field of a genome editing technique known as CRISPR, but the first U.S. patent was awarded to Feng Zhang, Doudna's partner at startup Editas Medicine. Charpentier, who founded CRISPR Therapeutics, says she retains some intellectual property rights. Doudna says the platform allows multiple players.

View Full Article in:

Scientist online, The · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide